VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$53.19
-0.44 (-0.82%)
▼
5d:
+12.38%
30d:
+17.7%
90d:
+67.05%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VCYT trades at premium valuation expecting 6.8% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: VCYT trades at premium valuation expecting 6.8% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$53.71
Based on 4.2% avg growth
INTRINSIC VALUE TODAY
$33.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $53.19, which is considered extended relative to its 30-day fair value range of $41.74 to $50.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 28.0) compared to its historical average (23.0). At these levels, the market is pricing in 6.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VCYT is in a strong uptrend. The price is approaching resistance at $54.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VCYT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VCYT is in a strong uptrend. The price is approaching resistance at $54.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VCYT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$41.74 -
$50.00
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($49.10)
- NEUTRAL: PE elevated vs history but 6.8% growth expectation is conservative given 289% recent growth
Trading Range Analysis
30-Day Trading Range
$41.74 -
$50.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$46.04
Resistance Level
$54.72
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.98
Wall Street Target
$49.10
(-7.7%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
288.9%
Profit Margin
16.2%
Valuation Premium vs History
+6.8% premium
PE vs Historical
28.0 vs 23.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.8%
(market-implied from PE analysis)
1-Year Target
$56.81
(+7%)
2-Year Target
$60.67
(+14%)
3-Year Target
$64.80
(+22%)
3-Yr Target (if PE normalizes)
(PE: 28→23)
PE COMPRESSION
$53.26
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.0, Growth: 4.4%)
$60.51
(+14%)
Base:
(SPY PE: 21.8, Growth: 4.4%)
$47.10
(-11%)
Bear:
(PE: 18.5, Growth: 4.4%)
$40.04
(-25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (50x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 49.66 | Current EPS (TTM): $1.08
Bull Case
$103.84
(+95%)
Analyst growth 76.0%, PE expands to 54.6
Base Case
$94.40
(+78%)
Market implied 76.0%, PE stable at 49.7
Bear Case
$36.47
(-31%)
Severe decline -20.0%, PE contracts to 42.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 4:26 AM ET
Data refreshes hourly during market hours. Next update: 5:26 AM
Data refreshes hourly during market hours. Next update: 5:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Leite
SELL
5260 shares
2026-03-04
Marc Stapley
SELL
45523 shares
2026-03-04
Rebecca Chambers
SELL
18341 shares
2026-03-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
